Visual Capitalist October 21, 2024
Jenna Ross

More people die every year directly from antimicrobial resistance than from HIV/AIDS, malaria, or any one form of cancer other than lung cancer. Clearly, a drug-resistant bacterial infection is a major health threat. But are researchers giving infections the attention they need?

In part two of this series on antimicrobial resistance, we partnered with the MSCI Sustainability Institute to show the gap between deaths related to bacterial infection and research efforts.

The Mismatch Between Deaths and Research

Globally, a bacterial infection causes nearly 14% of deaths. More than half of these deaths are linked to resistance. Unfortunately, fewer than 2% of all clinical trials study bacterial infections.

With rising antibiotic resistance, new drugs are desperately needed—but research isn’t keeping up....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Healthcare System, Physician, Provider, Public Health / COVID, Trends
How America Lost Control of the Bird Flu, Setting the Stage for Another Pandemic
Science magazine names HIV drug its 'Breakthrough of the Year'
Integrating Equity Into Licensing Agreements For Taxpayer-Funded Technologies
How Technology Could Speed And Support Disaster Response
Food recalls seem increasingly common. Why?

Share This Article